Achieve Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACHV and other ETFs, options, and stocks.About ACHV
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor.
CEORichard Alistair Balfour Stewart
CEORichard Alistair Balfour Stewart
Employees25
Employees25
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded1991
Founded1991
Employees25
Employees25
ACHV Key Statistics
Market cap232.10M
Market cap232.10M
Price-Earnings ratio-3.07
Price-Earnings ratio-3.07
Dividend yield—
Dividend yield—
Average volume588.68K
Average volume588.68K
High today$4.42
High today$4.42
Low today$4.24
Low today$4.24
Open price$4.24
Open price$4.24
Volume299.88K
Volume299.88K
52 Week high$5.78
52 Week high$5.78
52 Week low$1.84
52 Week low$1.84
Stock Snapshot
Achieve Life Sciences(ACHV) stock is priced at $4.36, giving the company a market capitalization of 232.1M. It carries a P/E multiple of -3.07.
During the trading session on 2025-12-18, Achieve Life Sciences(ACHV) shares reached a daily high of $4.42 and a low of $4.24. At a current price of $4.36, the stock is +2.8% higher than the low and still -1.4% under the high.
Trading activity shows a volume of 299.88K, compared to an average daily volume of 588.68K.
Over the past 52 weeks, Achieve Life Sciences(ACHV) stock has traded between a high of $5.78 and a low of $1.84.
Over the past 52 weeks, Achieve Life Sciences(ACHV) stock has traded between a high of $5.78 and a low of $1.84.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ACHV. This list is generated using Robinhood data, and it’s not a recommendation.